The VMD has voiced its “disappointment” at the profession-wide rejection of its proposals for a new medicines category, but claims it will continue to promote plans for the POM-EA classification.

The VMD has voiced its “disappointment” at the profession-wide rejection of its proposals for a new medicines category, but claims it will continue to promote plans for the POM-EA classification.

John FitzGeraldThe proposed “extended administration” class would cover products treating endemic conditions. Relevant products would initially be prescribed by a vet, but clients would be issued with a certificate enabling them to obtain repeat prescriptions from a pharmacist or SQP for up to 36 months.

Speaking at BCVA congress on November 27, VMD operations director John FitzGerald revealed that, of the 92 responses to the recent “unofficial” consultation, 90 objected to the proposals. Despite this, he said the VMD would continue to push the POM-EA classification in order to “generate a more positive response”.

He told delegates: “The VMD needs to get the message over as to how we see the category working. We didn’t necessarily sell the proposal very well, so we will go out and sell it again.”

For further details, see this week’s Veterinary Times (Vol. 39, No. 49).

View your activity >

Leave a Reply

Be the First to Comment!

Notify of
avatar

wpDiscuz